A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.

Saved in:
Bibliographic Details
Title: A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
Authors: Ahmad SS; ICMR-National Institute of Malaria Research, New Delhi, India., Verma R; ICMR-National Institute of Malaria Research, New Delhi, India., Commons RJ; WorldWide Antimalarial Resistance Network, Asia-Pacific Regional Hub, Melbourne, Australia.; Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; General and Subspecialty Medicine, Grampians Health, Ballarat, Australia., Nitika; ICMR-National Institute of Malaria Research, New Delhi, India., Singh-Phulgenda S; Infectious Diseases Data Observatory - IDDO, Oxford, UK.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, New Richards Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LG, UK., Chhajed R; Infectious Diseases Data Observatory - IDDO, Oxford, UK.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, New Richards Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LG, UK., Bharti PK; ICMR-National Institute of Malaria Research, New Delhi, India., Behera B; Delhi Skill and Entrepreneurship University, New Delhi, India., Naser SM; Calcutta National Medical College, Kolkata, West Bengal, India., Pal SK; Calcutta National Medical College, Kolkata, West Bengal, India., Ranjit PH; Calcutta National Medical College, Kolkata, West Bengal, India., Baharia RK; NIMR Field Unit, Academy of Scientific and Innovative Research, Ghaziabad, Gujarat, India., Solanki B; Ahmedabad Municipal Corporation, Ahmedabad, Gujarat, India., Upadhyay KJ; BJ Medical College, Ahmedabad, Gujarat, India., Guerin PJ; Infectious Diseases Data Observatory - IDDO, Oxford, UK.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, New Richards Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LG, UK., Sharma A; International Centre for Genetic Engineering and Biotechnology, New Delhi, India., Price RN; WorldWide Antimalarial Resistance Network, Asia-Pacific Regional Hub, Melbourne, Australia.; Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, New Richards Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LG, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Rahi M; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India. drmanjurahi@gmail.com.; Indian Council of Medical Research, New Delhi, India. drmanjurahi@gmail.com., Thriemer K; Menzies School of Health Research and Charles Darwin University, Darwin, Australia. kamala.ley-thriemer@menzies.edu.au.
Source: Trials [Trials] 2024 Feb 29; Vol. 25 (1), pp. 154. Date of Electronic Publication: 2024 Feb 29.
Publication Type: Clinical Trial Protocol; Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1745-6215
DOI:10.1186/s13063-024-07987-0